Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib. Read ...
A Conversation with Greg Lukianoff on Words, Violence, and Democratic Survival When Metaphors Become Mandates Last month, Greg Lukianoff stood in front of students at Utah Valley University and talked ...
Q2 2026 Earnings Call November 10, 2025 4:30 PM ESTCompany ParticipantsSteven Lisi - CEO & Chairman of the BoardDouglas Larson ...
Here are the top medical news for the dayIndia Ranks Second Globally With 138 Million Kidney Disease Cases in 2023: Study ...
Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the third quarter of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback